Please login or sign up to post and edit reviews.
Rethinking weight and health in the age of Ozempic
Podcast |
Where We Live
Media Type |
audio
Categories Via RSS |
Government
News
Society & Culture
Publication Date |
Mar 08, 2024
Episode Duration |
00:49:00

According to the National Institutes of Health, average body weight drastically increased across the board for men and women during the pandemic lockdown.

Simply eating less and exercising more hasn’t been that effective when it comes to weight loss. In efforts to fight weight stigma, doctors are embracing a new idea that weight loss isn’t all about willpower and health is defined by more than just someone’s weight.

In 2021, the FDA approved Semaglutide for weight loss for the general population. Doctors and patients are flocking to get this medication.

Children over the age of 12 are now eligible to be prescribed this drug as well. Many celebrities have confirmed their personal use of the drugs, including Oprah. Influencers across the social sphere are partnering with pharmaceutical companies to promote the drugs.

Today, we talk about these drugs, and combating weight stigma in and out the doctor’s office.

GUESTS:

  • Dr. Mara Gordon: Family Practice Physician from New Jersey
  • Devika Umashanker: System Medical Director for Obesity Medicine at Hartford Healthcare
  • Dr. Maria Asnis: Director of the Center for Weight Management at Stamford Health
  • Dr. Sherry Pagoto: Licensed Clinical Psychologist and Professor at University of Connecticut

Where We Live is available as a podcast on Apple Podcasts, SpotifyGoogle PodcastsAmazon MusicTuneInListen Notes, or wherever you get your podcasts. Subscribe and never miss an episode.

Support the show: http://wnpr.org/donate

See omnystudio.com/listener for privacy information.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review